Cimpress plc filed a definitive proxy statement on October 27, 2026, notifying shareholders of its 2026 Annual General Meeting to be held on December 8, 2026, at 5:00 p.m. Dublin Time at the offices of Matheson LLP in Dublin, Ireland.

Key Highlights

  • Meeting date and location: The annual general meeting will be held on December 8, 2026, at 70 Sir John Rogerson's Quay, Dublin 2, Ireland.
  • Director reappointment: Shareholders will vote on reappointing Sophie A. Gasperment to the Board of Directors for a three-year term ending at the conclusion of the 2029 annual general meeting.
  • Share issuance authority: Proposal 3 seeks to renew the Board's authority, until June 8, 2028, to issue ordinary shares up to a maximum of 20% of issued and outstanding share capital.
  • Preemption rights opt-out: Proposal 4, requiring at least 75% of votes cast as a special resolution, seeks authority to opt out of Irish statutory preemption rights for cash issuances up to 20% of issued and outstanding share capital.
  • Auditor reappointment: Shareholders will vote on reappointing PricewaterhouseCoopers Ireland as statutory auditor under Irish law through the conclusion of the 2027 annual general meeting.
  • Record date: Shareholders of record at the close of business on October 12, 2026, are entitled to attend, speak, and vote at the meeting.
  • Proxy deadline: To be valid, proxies must be received no later than 11:59 p.m. Eastern Standard Time on December 7, 2026.

Cimpress Puts Six Proposals Before Shareholders at December 2026 Meeting

According to the filing, Cimpress plc, an Irish-incorporated company listed on NASDAQ:CMPR, operates as a mass customization platform and is headquartered at Finnabair Business and Technology Park, Dundalk, Co. Louth, Ireland. The definitive proxy statement was mailed or made available to shareholders on or about October 28, 2026, together with the company's Annual Report to Shareholders for the fiscal year ended June 30, 2026.

The filing outlines six formal proposals for shareholder action. Five of the six proposals are structured as ordinary resolutions under Irish law, each requiring a simple majority of votes cast to pass. Proposal 4, which addresses the opt-out of statutory preemption rights under Irish law with respect to cash issuances of ordinary shares, is structured as a special resolution requiring at least 75% of votes cast in favor. The Board of Directors has stated, according to the filing, that it has "no knowledge of any other business to be transacted at the annual general meeting."

The proxy statement also includes a non-binding, advisory vote on the compensation of the company's named executive officers, as described in the proxy statement itself. In addition, during the meeting, management will present the company's statutory financial statements under Irish law for the fiscal year ended June 30, 2026, including reports from the directors and the Irish statutory auditor. The filing notes that shareholders who cannot attend in person may appoint one or more proxies, and that a proxy need not be a shareholder of Cimpress plc.

What Was Disclosed

Cimpress plc filed a definitive proxy statement covering six proposals for its December 8, 2026 Annual General Meeting, including director reappointment, executive compensation advisory vote, share issuance authority renewal, preemption rights opt-out, and auditor reappointment. The proxy was signed by Founder, Chairman and Chief Executive Officer Robert S. Keane.